
Brazil became the first developing country to guarantee free and universal access to zzso treatment, with zzso drugs zzso being delivered to nearly 190,000 zzso The analysis of zzso price evolution and market dynamics in Brazil can help anticipate issues soon to zzso other developing countries, as the 2010 revision of the World Health Organization guidelines shifts demand towards more expensive treatments, and, at the same time, current evolution of international legislation and trade agreements on intellectual property rights may reduce availability of generic drugs for zzso zzso 

Our analyses are based on effective prices paid for zzso procurement in Brazil between 1996 and zzso Data panel structure was exploited to gather zzso and zzso information and address various sources of statistical zzso zzso zzso offered in-depth information on zzso market characteristics which significantly influence zzso Although overall zzso prices follow a declining trend, changing characteristics in the generic segment help explain recent increase in generic zzso zzso Our results show that generic suppliers are more likely to respond to factors influencing demand size and market competition, while originator suppliers tend to set prices zzso to offset compulsory licensing threats and generic zzso 

In order to guarantee the long term zzso of access to zzso treatment, our findings highlight the importance of preserving and stimulating generic market dynamics to sustain developing zzso bargaining power in price negotiations undertaken with originator zzso 

